Status:
ACTIVE_NOT_RECRUITING
Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure
Lead Sponsor:
University of California, Davis
Conditions:
Linear Cutaneous Wound
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.
Detailed Description
The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis. We will use a split wound model, half of the wou...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Able to give informed consent themselves
- Patient scheduled for cutaneous surgical procedure along a flat surface suitable to application of the embrace with predicted primary closure.
- Able to apply dressings themselves.
- Willing to return for follow up visits.
Exclusion
- Mentally handicapped
- Unable to understand written and oral English
- Incarceration
- Under 18 years of age
- Pregnant Women
- Wounds with predicted closure length less than 3 cm
- Patients with known adverse reactions to adhesives
- Patients with history of collagen vascular disease
Key Trial Info
Start Date :
March 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03294863
Start Date
March 15 2017
End Date
December 15 2025
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis, Department of Dermatology
Sacramento, California, United States, 95816